This, along with its short life cycle and large biomass production capacity, makes it an ideal choice for quick and efficient recombinant protein production. However, despite these multiple ...

Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

As global markets navigate a landscape of tariff uncertainties and mixed economic signals, with U.S. stocks ending the week lower despite strong earnings reports from many companies, investors are ...

Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

In a second proposal, Laurus Bio received clearance for the commercial production of recombinant silk protein using GE Pichia pastoris strains. This synthetic bioengineered version of silk protein ...

Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing ...

Scientists have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer ...

Management is scheduled to give a corporate overview at the BIO CEO & Investor Conference on Tuesday, February 11, 2025 at 10:15 AM EST at the Royale Room and will be available to participate in ...